ZWHC:CA:TSX-BMO Covered Call Health Care ETF (CAD)

ETF | Others |

Last Closing

CAD 27.25

Change

+0.05 (+0.18)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

+0.44 (+1.37%)

CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.35 (+1.22%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

+0.46 (+1.84%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.61 (+1.80%)

CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.02%)

CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

-0.02 (-0.04%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.05 (+0.17%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.01 (+0.09%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

N/A

CAD 2.78B

ETFs Containing ZWHC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.51% 35% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.51% 34% F 33% F
Trailing 12 Months  
Capital Gain -4.25% 14% F 22% F
Dividend Return 3.94% 81% B- 72% C
Total Return -0.32% 16% F 23% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.95% 41% F 40% F
Dividend Return 2.99% 44% F 36% F
Total Return 1.04% 83% B 39% F
Risk Return Profile  
Volatility (Standard Deviation) 4.53% 83% B 93% A
Risk Adjusted Return 66.01% 73% C 73% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.